Diagnosis of MDR-TB in patients with risk factors for resistance.
- Ye Minn Htun (6166160)
- Tin Mi Mi Khaing (6166163)
- Nay Myo Aung (6166166)
- Yin Yin (2016565)
- Zaw Myint (6166169)
- Si Thu Aung (4707427)
- Ngamphol Soonthornworasiri (3121773)
- Udomsak Silachamroon (6166172)
- Yuthichai Kasetjaroen (6166175)
- Jaranit Kaewkungwal (190918)
Publication date
December 2018
DOI Publisher
Public Library of Science (PLoS)Abstract
R-res; Rifampicin Resistance. TAF-I; Treatment after Failure Category I. TAF-II; Treatment after Failure Category II. LPA; Line probe Assay. Cat I; Treatment for new patients with first-line anti-TB drugs (2HREZ/4HR). Cat II; Re-treatment regimen with first-line drugs (2SHREZ/1HREZ/3HRE).</p
Add to ORKG